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in observational epidemiology
From MURIELLE BOCHUD,1* ARNAUD CHIOLERO,1 ROBERT C ELSTON2 and FRED PACCAUD1
The concept of Mendelian randomization when
used in the context of association studies refers to
the random allocation of alleles at the time of gamete
formation. This concept has received a lot of attention
in recent years in observational epidemiology for
its potential to reduce residual confounding and
to protect against reverse causation.1 In brief, the
random segregation of alleles at the time of gamete
formation is a natural experiment that occurs before
the outcome of interest, which protects against falsely
reversing the inference about a cause-effect relation-
ship. If a particular genetic variant is strongly
associated with a risk factor for the outcome of
interest, the association between this genetic variant
and the outcome of interest may be used to infer
causality.
Table 1 indicates the commonly acknowledged
necessary conditions (1–9) for Mendelian randomiza-
tion to provide this protection in observational
epidemiology.2,3 We list additional necessary condi-
tions (10–12) that have been given little attention
and may be of relevance for certain genetic variants.
The first of these additional conditions is the
absence of transmission ratio distortion (TRD). TRD
occurs when the distribution of alleles at a particular
locus differs in the surviving offspring from that
expected on the basis of Mendelian proportions. TRD
can occur either during or after meiosis. Segregation
distortion or meiotic drive refers to the phenomenon of
non-random assignment of alleles at the time of
gamete formation and therefore describes TRD during
meiosis.4 After meiosis, TRD may result from selective
survival between conception and birth or later.
In humans, a few examples of TRD have been
reported.5–10 In particular, a recent report suggests
that transmission distortion may be widespread in the
human genome.6 Selective survival due to the genetic
variant of interest is acknowledged as a potential
source of bias analogous to differential loss of follow
up in randomized controlled trials.2 With that
perspective, selective survival may occur not only
between conception and birth, but also between birth
and entry into the study if the genetic variant of
interest causes early mortality.
The second additional condition is the absence of
parent-of-origin effect. A parent-of-origin effect occurs
whenever the effect of an allele on a phenotype of
interest depends on whether the allele was passed on
to the child from the father or from the mother.
Some genes may be silent or functionally active
depending on whether a particular variant was
maternally or paternally inherited. This effect is
mediated through an epigenetic modification called
imprinting. As a consequence, a parent-of-origin
effect implies that the effect on the phenotype
conferred by a specific genetic variant is not homo-
geneous in the population.
Segregation distortion and parent-of-origin effect
have, to our knowledge, not been previously described
as potential limitations to the use of Mendelian
randomization for inferring causality in observational
epidemiology. We consider here data on the relation-
ship between homocysteine blood level and stroke to
illustrate how these limitations may jeopardize the
use of Mendelian randomization to infer causation.
Homocysteine blood level is associated with
increased risk of stroke11 and is determined, in
part, by the activity of methylenetetrahydrofolate
reductase (MTHFR). The C677T MTHFR variant is
associated with both the risk of stroke and homo-
cysteine blood level.12 The risk of stroke conferred by
the C677T MTHFR variant is consistent with the risk
expected from the increased homocysteine blood
level associated with the C677T MTHFR variant.12
These findings strongly suggest a causal relationship
between homocysteine and stroke. We now consider
to what extent the earlier-mentioned conditions may
not have been met for this particular example.
Infante-Rivard and Weinberg13 assessed TRD for
variants in five genes associated with thrombophilic
disorders, including the MTHFR gene. They found
some evidence of TRD for the MTHFR gene, which
may be due to either segregation distortion at the
time of gamete formation or due to post-meiotic
events occurring between conception and birth.
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Furthermore, fetal C677T MTHFR status has been
associated with fetal viability, i.e. selective survival
between gamete formation and birth.14,15 Maternal
C677T MTHFR status may influence pregnancy
outcome. The C677T status of the mother has been
associated with idiopathic recurrent pregnancy losses
in some studies16–18 but not in others.19–22 Maternal
hyperhomocysteinemia could be a risk factor for
recurrent early pregnancy loss.23 Together, these
observations may contribute to TRD at this particular
locus and so invalidate the assumption of random
segregation of alleles that underlies Mendelian
randomization. Finally, although there is currently
no evidence for a parent-of-origin effect, few studies
have evaluated genomic imprinting at the C677T
MTHFR locus13 so far. Due to the growing evidence
for the role of imprinted genes in common complex
diseases,24–28 assuming that parent-of-origin effects
are absent may be disputable in many instances.
Hence, for this specific example, not only may the
process of randomization itself be flawed, but
substantial selective survival may also occur between
the time of randomization (i.e. gamete formation)
and the time of birth. As a consequence, the genotype
distribution at birth may differ from the distribution
at the time of randomization. The influence of
maternal C677T genotype and maternal homocysteine
levels on the fetal genotype distribution may represent
additional sources of bias.
Currently, little is known about the mechanisms
that distort the distribution of alleles from that
expected from Mendel’s first law between gamete
formation, conception, birth and entry into a study.
It is therefore difficult to estimate the extent to
which these mechanisms may affect the results of
Mendelian randomization studies. However, these
mechanisms should not be assumed to be negligible
until they have been properly evaluated. Potential
for segregation distortion, selective survival and
parent-of-origin effect should be kept in mind when
conducting Mendelian randomization studies to
draw causal inference in observational studies.
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Reply
From GEORGE DAVEY SMITH1* and SHAH EBRAHIM2
We thank Murielle Bochud and colleagues1 for their
letter regarding our two review articles on Mendelian
randomization.2,3 We agree with them that caution
needs to be applied to the interpretation of the
findings from Mendelian randomization studies. They
raise two new issues that we would like to comment
on. First, they suggest that transmission ratio distor-
tion (TRD) could generate spurious interpretations.
As we discussed in our first paper,1 true Mendelian
randomization would occur in studies relating to
genetic variant transmission from both parents to
their offspring and how this relates to offspring
outcomes. TRD could indeed lead to erroneous
conclusions in this setting. However, in practice,
Mendelian randomization studies have relied on the
generally well-supported notion that at a population
level, genetic variants are unrelated to socioeconomic,
behavioural and physiological confounding factors
that would distort the interpretation of conventional
epidemiological studies.4–10 In this case, TRD would
only lead to spurious conclusions if the distortion was
influenced by a maternal characteristic (such as folate
intake) that was socially patterned or demonstrated
intergenerational behavioural or environmental con-
tinuity in such a way that this leads to genotype, at a
population level, becoming associated with potential
confounding factors. While claims have been made in
this regard, we are not aware of robust evidence that
such selective TRD occurs at a level that has led to
associations between genetic variants and potential
confounders at the population level.10 However, we
acknowledge that this is a possibility.
Second, Bochud et al. raised the issue of parent-of-
origin effects. Again, in population level studies, this
will only lead to erroneous conclusions if the process is
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